What are FDA approved clinical applications of total human IVIg?

— Infection prevention in children > 2 years with congenital (primary) immmunodeficiency — Very efficient prevention of serious bacterial infections — Good tolerance — Subcutaneous use: practical, less severe fluctuations in Ig concentration — Infection prevention in leukemia patients with secondary immunodeficiency — Treatment of pediatric infections in HIV + children